European Archives - Page 459 of 1443 - European Medical Journal

Blood Pressure Fluctuations Linked to Cognitive Decline in Older Adults

A new study highlights the link between visit-to-visit blood pressure variability (BPV) and cognitive decline in older adults….

Blood Eosinophils and IL-8 Linked to Lung Decline in Asthma

Rising blood eosinophil counts and high sputum IL-8 levels predict accelerated lung function decline in asthma, highlighting key biomarkers for monitoring.

Revised Masking and Testing Strategies Reduce COVID-19 Spread

Results showed that ending universal testing and masking correlated with a notable increase in hospital-onset respiratory viral infections compared to community-onset cases.

Lung Clearance Index Shows ETI Benefits in Cystic Fibrosis

LCI detects lung function improvements in cystic fibrosis patients on ETI therapy, even when FEV1 changes are minimal, highlighting its clinical value.

Gut and Oral Microbiomes: Keys to Cirrhosis Outcomes

Cirrhosis-associated immune dysfunction heightens infection susceptibility through low-grade systemic inflammation and gut-liver axis alterations.

Advancing Prostate Cancer Care with Biomarker-Driven Insights

The study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC, particularly for select subgroups with favourable biomarkers.

Viral Persistence in Semen Linked to Disease Transmission

Viruses with pandemic potential, such as Ebola, Zika, and Lassa fever, demonstrated notable persistence in semen.

Baduanjin Exercise: A Promising Solution for Prostate Cancer Fatigue

Baduanjin consists of eight simple, flowing movements focusing on deep breathing, muscle relaxation, and mindful awareness.

Study Unveils Nasal Mycobiome’s Role in Allergic Rhinitis and Asthma

While prior research has focused on the nasal bacteriome, little attention has been paid to the nasal mycobiome, the community of fungi residing in the nasal cavity.

Radiation Therapy Shows Promise for Liver Cancer Survival

A phase 3 clinical trial suggests that stereotactic body radiation therapy prior to systemic treatment may improve survival outcomes for patients with liver cancer.